Total Payments
$3,751
2024 Payments
$1,194
Companies
23
Transactions
142
Medicare Patients
803
Medicare Billing
$26,396
Payment Breakdown by Category
Food & Beverage$3,735 (99.6%)
Education$16.02 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,735 | 141 | 99.6% |
| Education | $16.02 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $955.34 | 41 | $0 (2024) |
| Amgen Inc. | $470.81 | 9 | $0 (2024) |
| Novo Nordisk Inc | $350.67 | 16 | $0 (2024) |
| Lilly USA, LLC | $277.72 | 10 | $0 (2024) |
| GM Pharmaceuticals, Inc. | $233.67 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $220.85 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.62 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $134.64 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $127.54 | 9 | $0 (2023) |
| ABBVIE INC. | $124.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,194 | 38 | Amgen Inc. ($456.64) |
| 2023 | $1,165 | 44 | Bayer Healthcare Pharmaceuticals Inc. ($312.78) |
| 2022 | $864.02 | 33 | Bayer HealthCare Pharmaceuticals Inc. ($247.69) |
| 2021 | $527.73 | 27 | Bayer HealthCare Pharmaceuticals Inc. ($214.48) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: EndoVenous Therapies | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: VACCINES | ||||||
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardio-renal | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardio-renal | ||||||
| 06/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Cardio-renal | ||||||
| 06/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $135.01 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $100.42 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: Cardiology | ||||||
| 05/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Cardio-renal | ||||||
| 04/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Cardio-renal | ||||||
| 04/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 112 | 165 | $19,257 | $4,084 |
| 2022 | 13 | 258 | 301 | $22,532 | $9,160 |
| 2021 | 10 | 185 | 227 | $16,705 | $5,615 |
| 2020 | 11 | 248 | 297 | $23,930 | $7,537 |
Total Patients
803
Total Services
990
Medicare Billing
$26,396
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 48 | $15,452 | $2,875 | 18.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 15 | 23 | $920.00 | $301.76 | 32.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 18 | 27 | $1,134 | $279.45 | 24.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $614.41 | $204.10 | 33.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $535.92 | $188.40 | 35.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 14 | 21 | $334.00 | $128.31 | 38.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 14 | 21 | $267.00 | $106.68 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 47 | $9,400 | $3,237 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,800 | $1,585 | 56.6% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 23 | 27 | $3,194 | $1,375 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,820 | $866.39 | 47.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 25 | 30 | $1,200 | $397.95 | 33.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 27 | 34 | $1,428 | $355.65 | 24.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 21 | 21 | $630.00 | $343.33 | 54.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 17 | 17 | $510.00 | $273.16 | 53.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 11 | 12 | $360.00 | $199.05 | 55.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 17 | 20 | $400.00 | $192.47 | 48.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 21 | 26 | $390.00 | $160.48 | 41.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 21 | 26 | $260.00 | $133.43 | 51.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 14 | $140.00 | $41.76 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 52 | $10,400 | $3,342 | 32.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2021 | 16 | 18 | $2,142 | $923.58 | 43.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 22 | 28 | $1,120 | $374.92 | 33.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 25 | 34 | $1,428 | $359.04 | 25.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 11 | 11 | $330.00 | $179.08 | 54.3% |
About Lloyd Pina, NURSE PRACTITIONER
Lloyd Pina, NURSE PRACTITIONER is a Family healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1669990412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lloyd Pina, NURSE PRACTITIONER has received a total of $3,751 in payments from pharmaceutical and medical device companies, with $1,194 received in 2024. These payments were reported across 142 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,735).
As a Medicare-enrolled provider, Pina has provided services to 803 Medicare beneficiaries, totaling 990 services with total Medicare billing of $26,396. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Dallas, TX
- Active Since 08/31/2017
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669990412
Products in Payments
- Kerendia (Drug) $955.34
- Repatha (Biological) $264.68
- Vanacof (Drug) $233.67
- Otezla (Drug) $206.13
- Rybelsus (Drug) $192.36
- MOUNJARO (Drug) $187.17
- JARDIANCE (Drug) $168.45
- QULIPTA (Drug) $124.64
- AREXVY (Drug) $115.42
- AIRSUPRA (Drug) $115.22
- ImmunoCAP (Device) $113.48
- Ozempic (Drug) $71.11
- FARXIGA (Drug) $69.15
- KRISTALOSE (Drug) $60.89
- JANUVIA (Drug) $60.06
- Xofluza (Drug) $56.93
- Dexcom G6 Transmitter (Medical Supply) $53.87
- Cologuard Collection Kit (Device) $51.09
- TZIELD (Biological) $49.99
- Doc Band (Device) $49.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Dallas
Ms. Marcia Harris, Apn, APN
Family — Payments: $125,766
Family $125,766
Miles Horton, Fnp-C, FNP-C
Family — Payments: $62,774
Family $62,774
Zaineb Shams, Fnp-C, FNP-C
Family — Payments: $42,263
Family $42,263
Mrs. Katherine Bukolt, Arnp, ARNP
Family — Payments: $20,118
Family $20,118
Angelia Rose, Fnp, FNP
Family — Payments: $18,248
Family $18,248
Melissa Garcia, Fnp-C, FNP-C
Family — Payments: $14,544
Family $14,544